Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $271,174.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $16.40, for a total value of $271,174.00. Following the transaction, the president now owns 2,374,051 shares in the company, valued at approximately $38,934,436.40. The trade was a 0.69 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.99, for a total value of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total value of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Stock Up 2.7 %

ALHC traded up $0.45 on Wednesday, hitting $17.19. 2,791,742 shares of the company were exchanged, compared to its average volume of 1,412,390. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $17.41. The company has a market cap of $3.30 billion, a price-to-earnings ratio of -22.32 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The firm has a 50-day moving average price of $14.68 and a two-hundred day moving average price of $12.59.

Analysts Set New Price Targets

A number of equities research analysts have commented on ALHC shares. Barclays lifted their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research report on Friday, February 28th. Stifel Nicolaus lifted their target price on Alignment Healthcare from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Bank of America boosted their price objective on Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a report on Thursday, March 6th. Finally, Stephens reiterated an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. R Squared Ltd acquired a new position in Alignment Healthcare during the 4th quarter worth $55,000. RiverPark Advisors LLC acquired a new position in Alignment Healthcare during the 4th quarter worth $106,000. Tower Research Capital LLC TRC grew its stake in Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after purchasing an additional 6,286 shares in the last quarter. Ballentine Partners LLC acquired a new position in shares of Alignment Healthcare during the 4th quarter worth about $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Alignment Healthcare during the 3rd quarter worth about $131,000. 86.19% of the stock is owned by institutional investors and hedge funds.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.